Hangzhou Healthytide Biotechnology divulges new integrin α5β1 antagonists
Dec. 18, 2023
Hangzhou Healthytide Biotechnology Co. Ltd. has synthesized peptoids acting as integrin α5β1 (ITGA5; VLA-5) antagonists reported to be useful for the treatment of cancer and macular degeneration.